Printer Friendly

Applied Biosystems and Promega settle legal disputes.

Foster City, CA 9/5/06--Applied Biosystems has announced that it has entered into a settlement agreement with Promega, resolving all outstanding legal disputes. Settlement terms were not disclosed. Promega issued no statement.

According to Applera, Promega alleged in the 2001 suit that Applied Biosystems and three other companies (Lifecodes, Cellmark Diagnostics, Genomics International) infringed US Patents No. 6,221,598 and 5,843,660 (Multiplex Amplification of Short Tandem Repeat Loci). Applied Biosystems claimed Promega's products infringed its US Patent No. 6,200,748 (Tagged Extendable Primers and Extension Products).
COPYRIGHT 2006 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Executive Briefing: News, Trends & Market Intelligence for Instrument Executives
Publication:Instrument Business Outlook
Date:Sep 30, 2006
Previous Article:Thermo acquires maker of online elemental analyzers.
Next Article:Sigma-Aldrich settles with Enzo and Yale.

Related Articles
Real-time PCR companies eye clinical goldmine.
Patent litigation increases for selected techniques.
Applied Biosystems and Bio-Rad announce settlements in multiple cases.
Top business events of 2005.
New patent suits address groundbreaking techniques.
From the benchtop to the courtroom.
Applied Biosystems and Agilent settle patent suits.
Integration of LIMS.
Corbett files claim against Applied Biosystems.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |